Home Cart 0 Sign in  

[ CAS No. 80875-98-5 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
Chemical Structure| 80875-98-5
Chemical Structure| 80875-98-5
Structure of 80875-98-5 * Storage: {[proInfo.prStorage]}
Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Quality Control of [ 80875-98-5 ]

Related Doc. of [ 80875-98-5 ]

Alternatived Products of [ 80875-98-5 ]

Product Details of [ 80875-98-5 ]

CAS No. :80875-98-5 MDL No. :MFCD07782125
Formula : C9H15NO2 Boiling Point : -
Linear Structure Formula :- InChI Key :CQYBNXGHMBNGCG-FXQIFTODSA-N
M.W : 169.22 Pubchem ID :7408452
Synonyms :
(2S,3AS,7aS)-Octahydroindole-2-carboxylic acid
Chemical Name :H-Oic-OH

Calculated chemistry of [ 80875-98-5 ]

Physicochemical Properties

Num. heavy atoms : 12
Num. arom. heavy atoms : 0
Fraction Csp3 : 0.89
Num. rotatable bonds : 1
Num. H-bond acceptors : 3.0
Num. H-bond donors : 2.0
Molar Refractivity : 49.64
TPSA : 49.33 Ų

Pharmacokinetics

GI absorption : High
BBB permeant : Yes
P-gp substrate : No
CYP1A2 inhibitor : No
CYP2C19 inhibitor : No
CYP2C9 inhibitor : No
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -8.05 cm/s

Lipophilicity

Log Po/w (iLOGP) : 1.63
Log Po/w (XLOGP3) : -1.01
Log Po/w (WLOGP) : 0.61
Log Po/w (MLOGP) : -1.21
Log Po/w (SILICOS-IT) : 0.8
Consensus Log Po/w : 0.16

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 1.0
Bioavailability Score : 0.55

Water Solubility

Log S (ESOL) : -0.19
Solubility : 110.0 mg/ml ; 0.65 mol/l
Class : Very soluble
Log S (Ali) : 0.46
Solubility : 489.0 mg/ml ; 2.89 mol/l
Class : Highly soluble
Log S (SILICOS-IT) : -0.83
Solubility : 25.3 mg/ml ; 0.149 mol/l
Class : Soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 0.0 alert
Leadlikeness : 1.0
Synthetic accessibility : 2.54

Safety of [ 80875-98-5 ]

Signal Word:Warning Class:N/A
Precautionary Statements:P264-P280-P302+P352-P337+P313-P362+P364-P332+P313 UN#:N/A
Hazard Statements:H315-H319 Packing Group:N/A
GHS Pictogram:

Application In Synthesis of [ 80875-98-5 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Upstream synthesis route of [ 80875-98-5 ]
  • Downstream synthetic route of [ 80875-98-5 ]

[ 80875-98-5 ] Synthesis Path-Upstream   1~24

  • 1
  • [ 539820-41-2 ]
  • [ 80875-98-5 ]
YieldReaction ConditionsOperation in experiment
87% at 20℃; Introduce 200 g of the compound obtained in the previous Step, dissolved in acetic acid, and then 5 g of Pt/C 10percent into a hydrogenator. Hydrogenate under a pressure of 5 bars at ambient temperature until the theoretical amount of hydrogen has been absorbed. Remove the catalyst by filtration and then cool to a temperature of from 0 to 5° C. and collect the resulting solid by filtration. Wash the filter cake and dry it to constant weight. (2S, 3aS, 7aS)-Perhydroindole-2-carboxylic acid is obtained in that manner in a yield of 87percent and with an enantiomeric purity of 99percent.
Reference: [1] Patent: US2006/167273, 2006, A1, . Location in patent: Page/Page column 2
  • 2
  • [ 79815-20-6 ]
  • [ 80875-98-5 ]
YieldReaction ConditionsOperation in experiment
73.5% With 8 % Pd/C; hydrogen In methanol at 55 - 65℃; Autoclave In a 1 L autoclave,(S) -indoline-2-carboxylic acid (0.3 mol, 49.0 g) and methanol (600 mL)Then, 4.9 g of 8percent wet palladium carbon wetted with methanol was added,Mechanical agitation. Through the nitrogen replacement air 3 times,And then hydrogen gas replacement nitrogen 3 times,Replace the kettle when the pressure is 0.5Mpa. after finishing,Continue to hydrogen to 5.0Mpa, set the heating temperature at 60 ,Maintaining the temperature of the reaction system at 55 to 65 ° C,TLC (developing solvent: chloroform: methanol: triethylamine = 6: 4: 1, ninhydrin)Tracking to the raw point of the reaction is complete. The hydrogen was vented and the hydrogen was replaced with nitrogen three times.Discharge, filter, take the filtrate under reduced pressure,A crude solid was obtained as a white solid. Finally, recrystallization from ethanol,A white solid was obtained in 37.3 g yield, 73.5percent yield,Purity 98.6percent (HPLC),
Reference: [1] Patent: US4914214, 1990, A,
[2] Patent: CN104672124, 2017, B, . Location in patent: Paragraph 0137; 0138; 0139; 0140; 0141
[3] Journal of Medicinal Chemistry, 1991, vol. 34, # 2, p. 663 - 669
[4] Tetrahedron Letters, 1982, vol. 23, # 16, p. 1677 - 1680
[5] Patent: WO2005/100317, 2005, A1, . Location in patent: Page/Page column 12
[6] Patent: EP1792896, 2007, A1, . Location in patent: Page/Page column 10
  • 3
  • [ 89083-53-4 ]
  • [ 80875-98-5 ]
Reference: [1] Patent: EP1792896, 2007, A1, . Location in patent: Page/Page column 7; 9
  • 4
  • [ 79815-20-6 ]
  • [ 80875-98-5 ]
  • [ 145513-90-2 ]
Reference: [1] Tetrahedron, 2008, vol. 64, # 1, p. 84 - 91
[2] Chirality, 2011, vol. 23, # 7, p. 507 - 513
  • 5
  • [ 80875-99-6 ]
  • [ 80875-98-5 ]
Reference: [1] Journal of Medicinal Chemistry, 1987, vol. 30, # 6, p. 992 - 998
  • 6
  • [ 83508-14-9 ]
  • [ 80875-98-5 ]
Reference: [1] Patent: US2007/32661, 2007, A1, . Location in patent: Page/Page column 4
  • 7
  • [ 3770-50-1 ]
  • [ 80875-98-5 ]
Reference: [1] Journal of Medicinal Chemistry, 1987, vol. 30, # 6, p. 992 - 998
  • 8
  • [ 82864-25-3 ]
  • [ 80875-98-5 ]
Reference: [1] Tetrahedron Letters, 1982, vol. 23, # 16, p. 1677 - 1680
  • 9
  • [ 79854-42-5 ]
  • [ 80875-98-5 ]
Reference: [1] Tetrahedron Letters, 1982, vol. 23, # 16, p. 1677 - 1680
  • 10
  • [ 80828-13-3 ]
  • [ 80875-98-5 ]
Reference: [1] Journal of Medicinal Chemistry, 1987, vol. 30, # 6, p. 992 - 998
  • 11
  • [ 79799-08-9 ]
  • [ 80875-98-5 ]
Reference: [1] Journal of Medicinal Chemistry, 1987, vol. 30, # 6, p. 992 - 998
  • 12
  • [ 80828-31-5 ]
  • [ 80875-98-5 ]
Reference: [1] Journal of Medicinal Chemistry, 1987, vol. 30, # 6, p. 992 - 998
  • 13
  • [ 111836-10-3 ]
  • [ 80875-98-5 ]
Reference: [1] Tetrahedron Letters, 1987, vol. 28, # 13, p. 1413 - 1416
  • 14
  • [ 111836-07-8 ]
  • [ 80875-98-5 ]
Reference: [1] Tetrahedron Letters, 1987, vol. 28, # 13, p. 1413 - 1416
  • 15
  • [ 111836-08-9 ]
  • [ 80875-98-5 ]
Reference: [1] Tetrahedron Letters, 1987, vol. 28, # 13, p. 1413 - 1416
  • 16
  • [ 1521-51-3 ]
  • [ 80875-98-5 ]
Reference: [1] Tetrahedron Letters, 1987, vol. 28, # 13, p. 1413 - 1416
  • 17
  • [ 89-98-5 ]
  • [ 80875-98-5 ]
Reference: [1] Patent: CN104672124, 2017, B,
  • 18
  • [ 110592-39-7 ]
  • [ 80875-98-5 ]
Reference: [1] Patent: CN104672124, 2017, B,
  • 19
  • [ 116795-46-1 ]
  • [ 80875-98-5 ]
Reference: [1] Tetrahedron Letters, 1987, vol. 28, # 13, p. 1413 - 1416
  • 20
  • [ 111836-12-5 ]
  • [ 80875-98-5 ]
Reference: [1] Tetrahedron Letters, 1987, vol. 28, # 13, p. 1413 - 1416
  • 21
  • [ 80875-98-5 ]
  • [ 75-64-9 ]
  • [ 107133-36-8 ]
YieldReaction ConditionsOperation in experiment
86%
Stage #1: With chloro-trimethyl-silane; triethylamine In dichloromethane at 20 - 25℃; for 2 h;
Stage #2: With triethylamine In dichloromethane at -15℃; for 2 h;
Example 3 Preparation of perindopril erbumin from isopropyl acetate
((2S,3aS,7aS)-l-((2S)-2-(((lS)-l-
(ethoxycarbonyl)butyl)amino)-1-oxopropyl)octahydro-1H- indol-2-carboxylic acid 2-methylpropane-2-amine salt) ; Trimethylchlorosilane (2.92 ml) and triethyl amine (3.2 ml) were added to (2S,3aS,7aS)-octahydroindole-2-carboxylic acid (3.72 g) in dichloromethane (40 ml) at 20 - 25°C and it was stirred at 20 - 25°C for two hours. After two hours triethyl amine (2.77 ml) was added, the suspension was cooled to-15°C, a suspension of N-((S)-l-carbethoxybutyl)- L-alanyl chloride hydrochloride (5.5 g) in dichloromethane (80 ml), which had been cooled to-15°C, was poured thereto and the stirring was continued at-15°C for two hours. The reaction solution was heated to 0°C, the precipitated triethylamine hydrochloride was filtered off and washed with dichloromethane (10 ml), water (33 ml), wherein NaOH (0.8 g) had been dissolved, was added to the filtrate, and the pH was adjusted to 4.2 with a 20percent NaOH solution. The organic phase was separated and the aqueous layer was washed with dichloromethane (2 x 20 ml). The combined dichloromethane layers were evaporated, the residue was dissolved in isopropyl acetate (125 ml), the undissolved part was filtered off and t-butylamine (2.2 ml) was added to the filtrate. The precipitated crystals were dissolved at the boiling point of the solution, the clear solution was cooled to 10 - 20°C and the stirring was continued for two hours. After two hours the precipitated crystals were filtered off, washed with isopropyl acetate (15 ml) and dried at 35 - 40°C in an air drier. Perindopril erbumin (7.65 g; 86percent) in an a form having a purity over 99percent was obtained with individual impurities present in not more than 0.1percent each.
80%
Stage #1: With chloro-trimethyl-silane; triethylamine In dichloromethane at 20 - 25℃; for 2 h;
Stage #2: With triethylamine In dichloromethane at -15℃; for 2 h;
Example 2 Preparation of perindopril erbumin ((2S,3aS,7aS)-1-((2S)-2- (((lS)-l-(ethoxycarbonyl)butyl)amino)-l- oxopropyl) octahydro-1H-indol-2-carboxylic acid 2- methylpropane-2-amine salt) ; Trimethylchlorosilane (2.86 ml) and triethyl amine (3.08 ml) were added to (2S,3aS,7aS)-octahydroindole-2-carboxylic acid (3.72 g) in dichloromethane (60 ml) at 20 - 25°C and stirred at 20 - 25°C for two hours. After two hours triethyl amine (2.8 ml) was added, the suspension was cooled to -15°C, a suspension of N-((S)-l-carbethoxybutyl)- L-alanyl chloride hydrochloride (5.5 g) in dichloromethane (60 ml), which has been cooled to-15°C, was poured thereto and the stirring was continued at-15°C for two hours. The reaction solution was heated to 0°C, brine (25 ml) with dissolved NaOH (0.8 g) was added, and the pH was adjusted to 4.2 with a 20percent NaOH solution. The organic phase was separated and the aqueous layer was once more washed with dichloromethane (20 ml). The combined dichloromethane layers were evaporated, the residue was dissolved in ethyl acetate (100 ml), the undissolved part was filtered off and t-butylamine (2.2 ml) was added to the filtrate. The precipitated crystals were dissolved at the boiling point of the solution, the clear solution was cooled to 10 - 20°C and the stirring was continued for two hours. After two hours the precipitated crystals were filtered off, washed ,with ethyl acetate (12 ml) and dried at 35 - 40°C in an air drier. Perindopril. erbumin (7.1 g; 80percent) in an a form having a purity over 99percent was obtained with individual impurities present in not more than 0.1percent each.
78%
Stage #1: With chloro-trimethyl-silane; triethylamine In dichloromethane at 20 - 25℃; for 2 h;
Stage #2: With triethylamine In dichloromethane at -15℃; for 2 h;
Example Preparation of perindopril erbumin from N,N- dimethylformamide
((2S,3aS,7aS)-l-((2S)-2-(((lS)-l-
(ethoxycarbonyl)butyl)amino)-l-oxopropyl)octahydro-lH- indol-2-carboxylic acid 2-methylpropane-2-amine salt) ; Trimethylchlorosilane (2.92 ml) and triethyl amine (3.2 ml) were added to (2S,3aS,7aS)-octahydroindole-2-carboxylic acid (3.77 g) in dichloromethane (40 ml) at 20 - 25°C and stirred at 20 - 25°C for two hours. After two hours triethyl amine (2.77 ml) was added, the suspension was cooled to-15°C, a suspension of N-((S)-l-carbethoxybutyl)- L-alanyl chloride hydrochloride (5.5 g) in dichloromethane (40 ml), which had been cooled to-15°C, was poured thereto and the stirring was continued at-15°C for two hours. The reaction solution was heated to 0°C, the precipitated triethylamine hydrochloride was filtered off and washed with dichloromethane (10 ml), water (33 ml), wherein NaOH (0.8 g) had been dissolved, was added to the filtrate, and the pH was adjusted to 4.2 with a 20percent NaOH solution. The organic phase was separated and the aqueous layer was washed with dichloromethane (2 x 20 ml). The combined dichloromethane layers were evaporated, the residue was dissolved in N, N-dimethylformamide (90 ml),. the undissolved part was filtered off and t-butylamine ,(2.2 ml) was added to the filtrate. The precipitated crystals were dissolved at 80°C, the clear solution was cooled to 10 - 20°C and the stirring was continued for two hours. After two hours the precipitated crystals were filtered off, washed with N,N- dimethylformamide (9 ml) and dried at 35 - 40°C in an air drier. Perindopril erbumin (6.9 g; 78percent) in an a form having a purity over 99percent was obtained with individual impurities present in not more than 0.1percent each.
Reference: [1] Patent: WO2005/113500, 2005, A1, . Location in patent: Page/Page column 10-11
[2] Patent: WO2005/113500, 2005, A1, . Location in patent: Page/Page column 9-10
[3] Patent: WO2005/113500, 2005, A1, . Location in patent: Page/Page column 11-12
  • 22
  • [ 869877-95-2 ]
  • [ 80875-98-5 ]
  • [ 75-64-9 ]
  • [ 107133-36-8 ]
Reference: [1] Patent: US2006/211867, 2006, A1, . Location in patent: Page/Page column 3-4
  • 23
  • [ 80875-98-5 ]
  • [ 107133-36-8 ]
Reference: [1] Patent: CN104672124, 2017, B,
  • 24
  • [ 24424-99-5 ]
  • [ 80875-98-5 ]
  • [ 109523-13-9 ]
YieldReaction ConditionsOperation in experiment
100%
Stage #1: With sodium hydroxide In tetrahydrofuran; water for 0.166667 h;
Stage #2: at 20℃; for 12 h;
L-octahydroindole-2-carboxylic acid (1.69 g, 10 mmol) was added to the reaction flask,Add 30 mL of THF and 30 mL of distilled water to stir,A 7 mL aqueous solution of NaOH (0.68 g, 17 mmol) was added dropwise to the ice bath,Plus,The reaction was stirred for 10 min.(Boc) 2O (2.84 g, 13 mmol)Rose to room temperature for 12h.TLC detection reaction is completed, diluted with water, with methyl tert-butyl ether extraction impurity removal,The water phase with citric acid PH to acidic,Ethyl acetate was extracted three times, the organic phases were combined, washed with saturated brine, dried over Na2SO4,Filtration and concentration gave 3.21 g of compound 1 in 100percent yield.
98% With triethylamine In tetrahydrofuran; water at 20℃; Triethylamine (8.25 mL, 59 mmol) was added to (S)-octahydroindole-2- carboxylic acid (10.0 g, 59 mmol) in a 1/1 volume/volume mixture of tetrahydrofuran/water (200 ML total), followed by addition of di-tert-butyl dicarbonate (14.0 g, 65 mmol). The reaction mixture was stirred overnight at room temperature, and then concentrated with no heating to remove tetrahydrofuran. The aqueous mixture was partitioned between ethyl acetate (300 mL), water (100 mL), and citric acid solution (50 ML, 10percent aqueous). The layers were separated, the organic layer washed with brine (50 mL), dried (magnesium sulfate), filtered and concentrated to an oil, which solidified on standing. The solid was slurried in hexanes and collected by filtration. 15.63 g, 98percent. MS (APCI-) 17 1/Z (percent): 268 (100). Calcd for C14H23NO4 : C, 62.43 ; H, 8.61 ; N, 5.20 Found: C, 62.33 ; H, 8.30 ; N, 5.15
97% With sodium hydroxide In 1,4-dioxane; water at 20℃; for 18 h; To a stirred solution of (2S, 3aS, 7AS)-OCTAHYDROINDOLE-2-CARBOXYLIC acid (30 g, 0.18 mol) in dioxane (180 ML) and 1 M NAOH (180 mL), was added di- TE7X-BUTYL DICARBONATE (48 G, 0. 22 mol). The reaction mixture was stirred for 18 hours at room temperature and then diluted with diethyl ether (500 mL) and water (500 mL). The resulting aqueous layer was removed and cooled to 0 °C. Methylene chloride (1 L) was added, and the mixture adjusted to pH 3 by the addition of 2 M HC1. The organic layer was removed and the aqueous phase extracted with methylene chloride (2 x 25Q ML). The combined organic layers were dried over sodium sulfate, filtered and concentrated in vacuo to afford A colorless oil. Trituration with ether and hexanes followed by removal of the excess solvents afforded the desired (2S, 3aS, 7AS)-OCTAHYDROINDOLE-1, 2- dicarboxylic acid 1-TERT-BUTYL ester (4 6. 3 g, 97percent), as a white solid : NNM (300 MHz, DMSO-d6) 8 1.00-1. 70 (m, 7H), 1.32, 1.38 (2 s, 9H), 1.76-1. 98 (m, 2H), 2.01-2. 13 (m, 1H), 2.18-2. 33 (m, 1H), 3.59-3. 69 (m, 1H), 3. 99-4. 10 (m, 1H); MS (CI) 170 [M + H-100 (Boc)] +, 270 [M + H] +.
94% With triethylamine In dichloromethane (a)
To a solution of compound 5 in CH2Cl2 was added triethylamine and (Boc)2O.
The reaction was monitored by TLC.
After the starting materials were completely consumed, the mixture was diluted with CH2Cl2, washed sequentially with 1 N HCl and brine.
The organic layer was dried over Na2SO4, filtered, and evaporated to afford compound 6 as oil (94percent yield).
368 g
Stage #1: With sodium hydroxide In tetrahydrofuran; water at 0℃; for 0.25 h;
Stage #2: at 0 - 20℃; for 12 h;
To a stirred solution of (2R,3aS,7aS)-octahydro-lH-indole-2-carboxylic acid (250 g, 1.0 equiv) (1) in THF (3 L) and water (1.5 L) at 0 °C was added dropwise a cooled aqueous solution of 2.5 M NaOH (1 L). The reaction mixture was stirred for 15 minutes at the same temperature. Di-tert-butyl dicarbonate (1.3 equiv) was added dropwise, maintaining the temperature at 0 °C. The resulting reaction mixture was stirred at room temperature for 12 hours. The reaction mixture was washed with MTBE (3 times). The aqueous phase was acidified with IM aqueous citric acid and extracted with ethyl acetate (3 times). The combined organic layers were dried over sodium sulfate and concentrated to dryness to afford (2R,3a,S',7a)S)-l-(tert-butoxycarbonyl)octahydro-lH- indole-2-carboxylic acid (368 g) (2).

Reference: [1] Patent: CN106083829, 2016, A, . Location in patent: Paragraph 0061; 0065; 0067; 0068
[2] Patent: WO2004/92132, 2004, A1, . Location in patent: Page 85
[3] European Journal of Organic Chemistry, 2008, # 5, p. 934 - 940
[4] Patent: WO2004/92132, 2004, A1, . Location in patent: Page 80-81
[5] Bioorganic and Medicinal Chemistry, 2014, vol. 22, # 23, p. 6684 - 6693
[6] Journal of Medicinal Chemistry, 1996, vol. 39, # 12, p. 2379 - 2391
[7] Patent: US2012/302538, 2012, A1, . Location in patent: Page/Page column 17
[8] Patent: WO2018/64585, 2018, A1, . Location in patent: Page/Page column 28; 29
Same Skeleton Products
Historical Records